Quantoom Biosciences is reinventing mRNA production by developing an RNA Platform (Nfinity™) that encompasses DNA (Nplify™) and RNA (Ntensify™) manufacturing and formulation (Ncapsulate™), along with critical reagent supply, from sequence to large-scale production. We are a team of scientists, engineers, and clinicians committed to solving some of the biggest DNA and RNA production challenges facing vaccines and therapeutics, by delivering greater access and autonomy to mRNA technology. Our facilities are strategically located in Belgium and France, in the heart of Europe, benefiting from an exceptional biotech ecosystem. Quantoom Biosciences is part of Univercells, a global life sciences Group with the mission of making biologics accessible to all.

Biotechnology

Life Sciences

Pharmaceutical

Quantoom Biosciences

Jose Castillo

Wendy Glasset

Jessica van Berlamont

Oladimeji F.

Irina Gbalou

Oladimeji Fashola

Didier Masson

The Business Development Team at Quantoom Biosciences is responsible for identifying and cultivating strategic partnerships, driving market expansion, and fostering client relationships to enhance the adoption of Quantoom’s RNA Platform (Nfinity™). This team leverages their expertise to explore new business opportunities, manage key accounts, and support the company's mission to extend the reach of mRNA technology for vaccines and therapeutics globally.

Business Development Team

Operations

Leadership Team

Business Development Team

About

Team members

Other teams at Quantoom Biosciences

Operations

Leadership Team